SpaceX stock (NASDAQ: SPCX) has had a wild first few weeks as a public company. The shares, priced at $135 in the company’s record June 12 IPO, surged to an intraday high of $225.64 by June 16, and then slid to around $153 by June 27. That is a drop of roughly 32% from the… Continue reading Is SpaceX stock a bargain after its 32% post-IPO drop?
Stock Research
European shares hold steady as tech stocks gain amid Middle East ceasefire hopes
European equities traded little changed on Monday as gains in technology stocks helped offset broader market caution. Investors continued to assess the outlook for a fragile ceasefire in the Middle East after the United States and Iran agreed to halt their latest round of hostilities. The pan-European STOXX 600 index remained broadly unchanged at 636.13… Continue reading European shares hold steady as tech stocks gain amid Middle East ceasefire hopes
Why Samsung and SK Hynix stock are falling today
Samsung Electronics and SK Hynix fell on Monday even as South Korea prepared to unveil one of the biggest AI and chip investment drives in its history. That is the irony worrying investors. A spending plan that could reach as much as 2,000 trillion won, or about $1.3 trillion, would normally look bullish for the… Continue reading Why Samsung and SK Hynix stock are falling today
Apple and Microsoft hike prices due to memory: is AI becoming an inflation machine?
The artificial intelligence boom has long been pitched as a transformative force that would boost productivity and eventually lower costs across the economy. But this week, investors were confronted with a less discussed consequence of the AI race: higher prices. Apple and Microsoft both announced product price increases on Thursday, citing soaring costs for memory… Continue reading Apple and Microsoft hike prices due to memory: is AI becoming an inflation machine?
Why China’s top money managers believe the AI bubble is about to pop
A growing chorus of China’s most influential hedge fund managers is sounding the alarm on what they describe as a dangerously overheated global AI trade. After an explosive run-up in semiconductor and model‑development stocks from Seoul to Silicon Valley, several of Beijing’s money managers now argue the rally has detached from fundamentals – and that… Continue reading Why China’s top money managers believe the AI bubble is about to pop
Dow ends lower as AI selloff drags Nasdaq, defensive stocks gain
The Dow Jones Industrial Average and the broader US stock market closed lower on Friday as investors continued rotating out of technology and semiconductor stocks while shifting into more defensive sectors such as healthcare, consumer staples, and utilities. The S&P 500 slipped 0.27% to close at 7,337.68, while the Nasdaq Composite fell 0.48% to 25,236.88.… Continue reading Dow ends lower as AI selloff drags Nasdaq, defensive stocks gain
Apple stock gains on Friday as Wall Street sees buying opportunity
Apple Inc. (AAPL) shares have come under pressure after the company raised prices on several MacBook and iPad models. But some Wall Street analysts believe the pullback could present a buying opportunity as the company leverages its pricing power and loyal customer base. Apple stock fell 6.1% on Thursday after the company announced price increases… Continue reading Apple stock gains on Friday as Wall Street sees buying opportunity
Moderna stock soars as cancer pipeline and CAR-T push ignite optimism
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about 40% over the past month and significantly outperformed the broader market. The gains followed the company’s Science Day presentation and investor event, where Moderna outlined an ambitious strategy to expand beyond its COVID-19 vaccine business and… Continue reading Moderna stock soars as cancer pipeline and CAR-T push ignite optimism
Omeros stock crashes on regulatory setback: buy the dip?
Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europe that has caught investors off guard. Investors are bailing on OMER mostly because the European Medicines Agency’s (EMA) expert panel has rejected its primary commercial asset. At the time of writing, Omeros stock is down some 50% versus the… Continue reading Omeros stock crashes on regulatory setback: buy the dip?
